Frank Reed

A hedge fund's move on Spectris plc reveals a quiet battle for the precision instruments that power the future of medicine and life sciences.

A mandatory disclosure shows asset manager Rathbones trimming its stake in Empiric Student Property, offering a glimpse into institutional strategy.

A $2.4B semiconductor deal seems far from medicine. Yet, Qualcomm's acquisition of Alphawave is building the digital nervous system for AI diagnostics.

A $2.4B bid for a UK chip designer reveals the fierce M&A war for the silicon that will power the future of AI diagnostics and precision medicine.

Hedge fund Balyasny reveals a 1.25% stake in Empiric Student Property amid a major merger, signaling a calculated move in a red-hot market.

An amended disclosure from Weiss Asset Management on its Bluefield Solar stake offers a rare glimpse into complex derivative strategies and the high stakes of data accuracy.

A regulatory filing reveals a key investor's move in the Alphawave-Qualcomm deal, highlighting the high-stakes battle for tech that powers future health AI.

A landmark report tracking nearly 800 partnerships since 2016 reveals the high-stakes strategy shaping a new era of cures and personalized medicine.

A new report reveals over 500 diagnostic deals are reshaping medicine. We decode the strategy, the players, and what it means for the future of patient care.

A rare regulatory filing reveals a sophisticated options strategy, offering a window into the high-stakes investor chess match shaping our connected future.

A regulatory filing reveals Balyasny's stake in the Unite-Empiric merger, using derivatives to bet on the deal's success. What does it signal?

A hedge fund's derivative play in the Unite-Empiric takeover reveals intense M&A activity and "smart money" confidence in the UK's booming student housing market.

With a new CEO and focused strategy, Prime Medicine faces investors to prove its 'search and replace' gene editor is worth the wait in a crowded field.

A routine UK filing reveals Driehaus Capital's small sale of Greencore shares, offering a glimpse into active management and market sentiment.

A regulatory filing reveals a key investor's growing stake in Avadel, signaling potential M&A activity for the narcolepsy drugmaker.

Balyasny Asset Management's big bet on Avadel Pharmaceuticals' takeover reveals a fierce battle for LUMRYZ™, a next-gen narcolepsy treatment.

A regulatory filing reveals a top hedge fund's tactical moves in Unite's bid for Empiric, offering a rare glimpse into the high-stakes M&A chess game.

A major hedge fund's regulatory filing reveals a strategic stake in the Unite-Empiric merger, signaling big money's confidence in student property.

Dr. Lynne J. Baldwin of BHMI receives Pioneer Award, recognizing her leadership in back-office payment solutions and commitment to fostering women's entrepreneurship in the Midwest.

Leading clinical research organization AMR Clinical announces a strategic leadership shift as founder Dr. William Smith steps into a Vice Chairman role. The move signals a focus on scaling operations and capitalizing on rising demand for integrated research solutions.